Indacaterol, A Novel Once Daily Inhaled β2-Adrenoreceptor Agonist
Authors:
- Jorge RoigJRJorge Roig
- Ramon MoraRMRamon Mora
Open Access
- 12 March 2009
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Respiratory Medicine Journal
- Vol. 03 (1) , 27-30
Abstract
In this article we will review the role of long acting β2-adrenoreceptor agonists and long-acting muscarinic agents in the management of airflow obstruction. We will then focus our attention on indacaterol, one of the new once daily inhaled β2-adrenoreceptor agonists. Pharmacologically this drug is a nearly full β2-agonist without loss of efficacy after prolonged administration. We will also discuss its dosing, safety and tolerability.Keywords
This publication has 31 references indexed in Scilit:
- 24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterolCurrent Medical Research and Opinion, 2008
- Novel long‐acting bronchodilators for COPD and asthmaBritish Journal of Pharmacology, 2008
- Pharmacological Characterization of Indacaterol, a Novel Once Daily Inhaled β2 Adrenoceptor Agonist, on Small Airways in Human and Rat Precision-Cut Lung SlicesThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2007
- Indacaterol provides sustained 24 h bronchodilation on once‐daily dosing in asthma: a 7‐day dose‐ranging studyAllergy, 2007
- Tolerability of indacaterol, a novel once-daily β2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety studyAnnals of Allergy, Asthma & Immunology, 2007
- Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthmaEuropean Respiratory Journal, 2007
- Ultra-Long-Acting ??2-Adrenoceptor AgonistsDrugs, 2007
- Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthmaCurrent Medical Research and Opinion, 2007
- Systemic effects of salbutamol and salmeterol in patients with asthma.Thorax, 1994